Millie
your market intelligence analyst
Search Results
318 results
Your search is now limited to «Gilead» expert search.
Reuters.com 07/19/2019 13:11
Gilead Sciences Inc:
More from Reuters.com:
FierceMedicalDevices 07/19/2019 09:40
RELATED: Gilead CSO, R&D head McHutchison the latest to bid company adieu “Today’s announcement builds on Gilead’s heritage in antiviral research and development.
More from FierceMedicalDevices:
FiercePharmaManufacturing 07/19/2019 09:22
As filgotinib filing nears, Gilead should nab Celgene's Otezla, analysts say.
More from FiercePharmaManufacturing:
ENDPOINTS 07/19/2019 09:09
Gilead CEO Daniel O’Day’s new task hunting up a CSO for the company isn’t stopping the industry’s dominant antiviral player from doing pipeline deals.
More from ENDPOINTS:
Business Wire 07/19/2019 08:30
All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements.
More from Business Wire:
Xconomy 07/19/2019 06:45
The opioid crisis reaches all corners of the nation, and newly released data this week revealed how the growth of the epidemic tracked with a massive increase in the production and distribution of these drugs. From 2006 to 2012, the number of pills distributed to pharmacies increased by more than 50 percent. In total, 76 […]
More from Xconomy:
STAT 07/18/2019 15:23
Can apps treat anxiety? Is Gilead Sciences back on track? And are we all just brains in a vat?
More from STAT:
Pharmafile 07/18/2019 12:03
Gilead’s Chief Scientific Officer and Head of Research and Development has decided to leave the company next month, Gilead said.
More from Pharmafile:
FierceBiotech 07/18/2019 08:54
Gilead inks $5B upfront deal to gain broad access to Galapagos' pipeline Gilead Sciences is paying $5.1 billion (€4.5 billion) to enter into a 10-year collaboration with Galapagos.
More from FierceBiotech:
The lawsuit filed Friday against Gilead in Alameda County names 40 plaintiffs who have been injured from Gilead’s TDF-based drugs.
More from Pharmaceutical Business Review:
PharmiWeb.com 07/17/2019 08:21
According to a newly published report by market.us, “Worldwide Cystic Fibrosis (CF) Therapeutics Market: Information About Key Drivers, Restraints, And Opportunities 2019-2028“. The prime objective of the report is to deliver a Ten-year (2019-2028) market forecast. The latest study focusing on cystic fibrosis (cf) therapeutics market with topmost companies, to determine, define and analyses the sales size, value, market share, market competition landscape, and recent development. It helps to dec…
More from PharmiWeb.com:
Seeking Alpha 07/16/2019 19:39
Oscar Wilde I am getting quite a few questions on Gilead Sciences' (GILD) move Monday to substantially increase its investment in developmental partner Galapagos (GLPG.
More from Seeking Alpha:
PharmaManufacturing 07/16/2019 16:07
Kite, a Gilead company, announced plans for a new 67,000-square-foot facility in Oceanside, California, that is dedicated to the development and manufacturing of viral vectors.
More from PharmaManufacturing:
PharmTech.com 07/16/2019 13:00
GileadSciences, Inc. and Galapagos NV announced that they have entered into a 10-year global research and development collaboration, giving Gilead access to six molecules in clinical trials, more than 20 preclinical programs, a Galapagos’ drug discovery platform, and an exclusive product license and option rights to develop and commercialize current and future programs in countries ...
More from PharmTech.com:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications